IRTC Company Profile and Key Details

Q: Who are the executives of IRTC?

Mr. Brice Bobzien C.P.A.Chief Financial OfficerMr. Patrick Michael Murphy J.D.Chief Bus. & Legal OfficerMr. Douglas J. DevineExecutive AdvisorMr. Mazi KianiSenior Vice President of Quality & RegulatoryMr. Mark J. Day Ph.D.Chief Technology OfficerMr. Quentin S. BlackfordPres, Chief Executive Officer & DirectorMr. Brice Bobzien CPAChief Financial OfficerMs. Sumi ShrishrimalExecutive Vice President & Chief Risk OfficerMr. Chad M. PattersonChief Commercial OfficerDr. Minang P. Turakhia M.D., M.S.Chief Medical & Scientific Officer and Executive Vice President of Product InnovationMr. David A. VortStrategic AdvisorMr. Daniel G. WilsonExecutive Vice President of Corporation StrategyDr. Mintu P. Turakhia M.D.Chief Medical Officer & Chief Scientific OfficerDr. Mintu P. Turakhia M.D., M.S.Chief Medical & Scientific Officer and Executive Vice President of Product InnovationMs. Reyna M. FernandezChief HR OfficerStephanie ZhadkevichDirector of Investor Relations

NASDAQ : IRTC

iRhythm Technologies

$127.84

-0.28-0.22%

At Close 4:00 PM

56.32

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

iRhythm Technologies, Inc. (IRTC) stock declined over -0.22%, trading at $127.84 on NASDAQ, down from the previous close of $128.12. The stock opened at $131.57, fluctuating between $123.56 and $136.70 in the recent session.

Stock Snapshot

128.12

Prev. Close

4.2B

Market Cap

123.56

Day Low

-199.75

P/E Ratio

-0.64

EPS (TTM)

-2.95

Cash Flow per Share

131.57

Open

32.86M

Number of Shares

136.695

Day High

98.83%

Free Float in %

6.84

Book Value

1.79M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 07, 2026	131.57	136.70	123.56	127.84	1.83M
Aug 06, 2026	122.82	128.48	122.11	128.12	1.2M
Aug 05, 2026	125.23	130.00	123.70	124.50	517.23K
Aug 04, 2026	124.00	127.79	124.00	127.13	636.35K
Aug 03, 2026	119.37	124.83	118.09	124.66	704.84K
Jul 31, 2026	117.49	120.11	116.50	117.17	469.83K
Jul 30, 2026	120.00	122.90	118.35	119.08	728.46K
Jul 29, 2026	116.31	123.75	116.31	122.44	918K
Jul 28, 2026	113.83	118.33	113.83	117.37	492.6K
Jul 27, 2026	110.81	114.51	110.81	112.15	427.51K
Jul 24, 2026	109.12	109.84	106.39	109.20	317.85K
Jul 23, 2026	107.00	107.92	105.68	107.67	383.48K
Jul 22, 2026	108.67	109.28	105.28	106.07	334.41K
Jul 21, 2026	109.82	111.55	108.78	109.00	369.74K
Jul 20, 2026	110.68	113.10	109.41	111.37	316.65K
Jul 17, 2026	113.94	114.99	108.30	110.88	681.25K
Jul 16, 2026	113.79	120.48	111.00	115.35	471.82K
Jul 15, 2026	111.78	115.77	110.00	113.26	383.86K
Jul 14, 2026	116.87	117.61	111.03	112.55	540.71K
Jul 13, 2026	117.54	118.74	115.11	118.68	617.06K

Contact Details

San Francisco, CA 94103

United States

https://www.irhythmtech.com 415 632 5700

About Company

iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.

Stock Peers

SWAV

-0.08-0.02%

ShockWave Medical, Inc.$334.75 UFPT

2.14+0.69%

UFP Technologies, Inc.$314.01 MASI

Masimo Corporation$179.95 ALGN

4.58+2.71%

Align Technology, Inc.$173.66 PODD

1.87+1.34%

Insulet Corp.$141.17 IRMD

1.285+1.41%

IRadimed Corporation$92.50 DXCM

1.73+2.08%

DexCom, Inc.$84.75 TMDX

3.68+4.59%

TransMedics Group, Inc.$83.89 NARI

Inari Medical, Inc.$79.97 ESTA

-1.63-2.06%

Establishment Labs Holdings Inc.$77.42

Company Overview

iRhythm Technologies, Inc. (NASDAQ:IRTC) closed at $127.84 USD, losing -$0.28 (-0.22%) from the previous close of $128.12. The stock is currently mid-range between its 52-week high and low $100.85 and $212.00. With a market capitalization of about $4.20 billion, iRhythm Technologies, Inc. is classified as a mid-cap and shows market-like volatility (beta ~1.27). Key stats such as the average daily volume over the past year has been around 593.71 thousand shares, trading with heavier-than-usual volume. Headquartered in San Francisco, CA, iRhythm Technologies, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Quentin S. Blackford, the company employs approximately 2,400 people and listed since October 20, 2016. iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 -5.86%, SMA50 -13.7%, SMA200 -13.67%). The stock’s 14-day RSI is 39.55 (weak momentum), while the ATR of 8.16 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -33.88% below its high and over 51.51% above its low. Average 10-day trading volume of 875.77 thousand shares is slightly above the 3-month average of 589.58 thousand, indicating heightened recent market interest.

Valuation Metrics

iRhythm Technologies, Inc. trades at a P/E ratio of -299.02, slightly below the S&P 500 average, with a price-to-sales ratio of 5.12 and a price-to-book ratio of 22.74 reflecting a rich premium to book value. The P/FCF stands at 716.18, also below market averages. Compared to sector medians, iRhythm Technologies, Inc. P/S is trading rich, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

Dividend & Fair Value

iRhythm Technologies, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $163.34. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

iRhythm Technologies, Inc. generated EPS of -$1.41 over the past year. Five-year average earnings growth is 2.49%. The latest quarter delivered EPS of $0.58. The next quarter is forecast at -$0.62. Next year's EPS is expected at $30.66. Analyst sentiment is bullish. Analyst rating data shows there are 14 Strong Buy ratings, 25 Buy ratings, 5 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $255.00 to $147.00. The high target offers 99.47% upside. The low target suggests 14.99% downside. The mean target is $198.25. This offers 55.08% upside. iRhythm Technologies, Inc. earnings surprise history is a mixed track record. The quarter that ended August 06, 2026, missed forecasts by -1550.0%. The prior quarter beat by -35.28%. Over the last six quarters, Apple has recorded several small beats. These include 6.74% in May 01, 2025.

Shareholding & Insider Activity

iRhythm Technologies, Inc. has 32.86 million shares outstanding. The public float is 30.79 million shares, elevated short interest at 10.54% of float. This equals 3.43 million shares. The short ratio is 5.39 days. Institutional investors hold 111.54% of the float. Insiders own 1.16%. King Kevin M holds 250.42 thousand shares, Blackford Quentin S. has 204.16 thousand shares and Murphy Patrick Michael has 63.20 thousand shares. Over the past six months, insider transactions show net selling. They sold 98.76 thousand shares across 27 transactions.

Financial & Profitability Overview

Over the trailing twelve months, iRhythm Technologies generated $492.68M in revenue, or $16.14 per share. Gross margin was 67.35%, operating margin -23.16%, and net profit margin -25.05%. Returns are negative, with ROA at -28.49% and ROE at -58.74%.
On valuation metrics, iRhythm Technologies trades at a P/E of -299.02, P/S of 5.12 and P/B of 22.74. The current ratio is 3.85 and quick ratio is 3.74. Operationally, the company’s inventory turnover is 10.47 and cash conversion cycle is 45.17 days. Debt-to-equity is 3.91, supported by a cash flow-to-debt ratio of 0.08.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, iRhythm Technologies posted revenue of $492.68M, down slightly from $410.92M in the prior quarter. Gross profit was $331.81M (margin 67.35%). Operating income was - $114.08M (margin -23.2%). Net income was- $123.41M (EPS - $4.04).
The company ended the quarter with $133.76M in cash and short-term investments, a total debt of $129.82M, and net debt of $93.65M. Total assets were $433.14M, with equity of $210.10M. Financials further reflected weakness, with operating cash flow of - $50.10M, free cash flow of - $90.53M, and capital expenditures of - $40.42M.

Price Forecast & Outlook

Our AI price prediction model suggests that iRhythm Technologies, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 0.66%, with price expected at $128.69 by August 21, 2026, within a range of $120.80 to $136.77 3-Month Outlook: Projected rise of 46.25%, reaching $186.96 by November 04, 2026, with a range of $179.12 to $194.49. 1-Year Outlook: Projected gain of 10.33%, with price at $141.04 by August 06, 2027, within a range of $132.93 to $153.01.

Key Takeaways

iRhythm Technologies, Inc. (NASDAQ:IRTC) shares are flat -6.67% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows iRhythm Technologies, Inc. trading at a premium to the broader market with a P/E of -299.02. Analyst sentiment is bullish, with the majority of ratings in Overweight territory and a mean price target of $162.28, suggesting 26.94% upside. Our AI forecast model points to short-term strength (0.66% over two weeks), a medium-term rise (46.25% over three months), and a longer-term gain (10.33% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current iRhythm Technologies, Inc. (IRTC) stock price?

iRhythm Technologies, Inc. (NASDAQ: IRTC) stock price is $127.84 in the last trading session. During the trading session, IRTC stock reached the peak price of $136.70 while $123.56 was the lowest point it dropped to. The percentage change in IRTC stock occurred in the recent session was -0.22% while the dollar amount for the price change in IRTC stock was - $0.28.

IRTC's industry and sector of operation?

The NASDAQ listed IRTC is part of Medical - Devices industry that operates in the broader Healthcare sector. iRhythm Technologies, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IRTC?

Mr. Brice Bobzien C.P.A.
Chief Financial Officer
Mr. Patrick Michael Murphy J.D.
Chief Bus. & Legal Officer
Mr. Douglas J. Devine
Executive Advisor
Mr. Mazi Kiani
Senior Vice President of Quality & Regulatory
Mr. Mark J. Day Ph.D.
Chief Technology Officer
Mr. Quentin S. Blackford
Pres, Chief Executive Officer & Director
Mr. Brice Bobzien CPA
Chief Financial Officer
Ms. Sumi Shrishrimal
Executive Vice President & Chief Risk Officer
Mr. Chad M. Patterson
Chief Commercial Officer
Dr. Minang P. Turakhia M.D., M.S.
Chief Medical & Scientific Officer and Executive Vice President of Product Innovation
Mr. David A. Vort
Strategic Advisor
Mr. Daniel G. Wilson
Executive Vice President of Corporation Strategy
Dr. Mintu P. Turakhia M.D.
Chief Medical Officer & Chief Scientific Officer
Dr. Mintu P. Turakhia M.D., M.S.
Chief Medical & Scientific Officer and Executive Vice President of Product Innovation
Ms. Reyna M. Fernandez
Chief HR Officer
Stephanie Zhadkevich
Director of Investor Relations

How IRTC did perform over past 52-week?

IRTC's closing price is 26.77% higher than its 52-week low of $100.85 where as its distance from 52-week high of $212.00 is -39.7%.

How many employees does IRTC have?

Number of IRTC employees currently stands at 2,400.

Link for IRTC official website?

Official Website of IRTC is: https://www.irhythmtech.com

How do I contact IRTC?

IRTC could be contacted at phone 415 632 5700 and can also be accessed through its website. IRTC operates from 699 8th Street, San Francisco, CA 94103, United States.

How many shares of IRTC are traded daily?

IRTC stock volume for the day was 1.79M shares. The average number of IRTC shares traded daily for last 3 months was 593.71K.

What is the market cap of IRTC currently?

The market value of IRTC currently stands at $4.20B with its latest stock price at $127.84 and 32.86M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	2400
Beta	1.27
Sales or Revenue	$492.68M
5Y Sales Change%	1.617%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

IRTC Company Profile and Key Details

iRhythm Technologies

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Company Overview

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Price Forecast & Outlook

Key Takeaways